FDA study shows asthma drug worsens asthma conditions. Brilliant.
The FDA warned yesterday that Advair, an commonly prescribed asthma medication from pharmaceutical company GlaxoSmithKline Plc. , should not be used in the long-term because, Bloomberg reports, they contain long-acting beta agonists, which “have been linked to increased risk of worsening asthma symptoms, hospitalizations and deaths.” As you might expect, this has had some negative effects on the sales of the drug, as most asthma patients want their conditions to “improve” and not “worsen,” but makers of the drug insist that it is a perfectly viable solution for short-term treatment of the respiratory disease.
-Michael B. Sauter
[...] often that Pfizer or GSK – two of the largest pharmaceutical companies in the world – make the news for something other than a scandal these days, but that’s exactly what happened last week [...]
[...] appears the Swiss pharma giant can do nothing right these days. First, there was Advair, the asthma drug that worsened the condition with prolonged use, then there was Avandia, the [...]